| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200101 | Ophthalmology | 2015 | 8 Pages |
Abstract
Among children 12 to 35 months of age with previously untreated IXT, deterioration over 6Â months was uncommon, with or without patching treatment. There was insufficient evidence to recommend part-time patching for the treatment of IXT in children in this age group.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Pediatric Eye Disease Investigator Group Pediatric Eye Disease Investigator Group, Brian G. MD, Susan A. OD, MS, Danielle L. MSPH, Jonathan M. BM, BCh, Angela M. OD, MS, Michele ScM, Sean P. MD, PhD, David K. MD, MPH, Raymond T. MSPH, Melanie L. COA,